Evidence map›Paper›PMID 25122028›Full record

ArticleAmerican journal of public health2015

Enhancing diversity in the public health research workforce: the research and mentorship program for future HIV vaccine scientists.

Carrie J Sopher, Blythe Jane S Adamson, Michele P Andrasik, Danna M Flood, Steven F Wakefield, David M Stoff, Ryan S Cook, James G Kublin, Jonathan D Fuchs

Abstract read
In one paragraph

Article in American journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Advancing Aging Research Through a Health Disparities Perspective.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  6. Article
  7. Article
  8. The national institute on drug abuse diversity scholars network: success for a diverse addiction science workforce.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carrie J SopherCarrie J. Sopher, Blythe Jane S. Adamson, Michele P. Andrasik, Danna M. Flood, Steven F. Wakefield, Ryan S. Cook, and James G. Kublin are with the HIV Vaccine Trials Network, Fred Hutchinson Cancer Research Center, Seattle, WA. David M. Stoff is with Neuropsychiatry of HIV/AIDS, AIDS Research Training, HIV/AIDS Health Disparities, Division of AIDS Research, National Institute of Mental Health, Bethesda, MD. Jonathan D. Fuchs is with San Francisco Department of Public Health and University of California, San Francisco, CA.
Blythe Jane S Adamson
Michele P Andrasik
Danna M Flood
Steven F Wakefield
David M Stoff
Ryan S Cook
James G Kublin
Jonathan D Fuchs

Funding

LOC: HIV Vaccine Trials NetworkUM1AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Dan H. Barouch, Lawrence Corey · 2011 to 2026
$1175.6M
Leadership Group for a Global HIV Vaccine Clinical Trials NetworkU01AI068614 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE · 2006 to 2010
$181.5M
NIAID NIH HHS UM1 AI068614
6 · The paper itself

Abstract

objectivesWe developed and evaluated a novel National Institutes of Health-sponsored Research and Mentorship Program for African American and Hispanic medical students embedded within the international, multisite HIV Vaccine Trials Network, and explored its impact on scientific knowledge, acquired skills, and future career plans.

methodsScholars conducted social, behavioral, clinical, or laboratory-based research projects with HIV Vaccine Trials Network investigators over 8 to 16 weeks (track 1) or 9 to 12 months (track 2). We conducted an in-depth, mixed-methods evaluation of the first 2 cohorts (2011-2013) to identify program strengths, areas for improvement, and influence on professional development.

resultsA pre-post program assessment demonstrated increases in self-reported knowledge, professional skills, and interest in future HIV vaccine research. During in-depth interviews, scholars reported that a supportive, centrally administered program; available funding; and highly involved mentors and staff were keys to the program's early success.

conclusionsA multicomponent, mentored research experience that engages medical students from underrepresented communities and is organized within a clinical trials network may expand the pool of diverse public health scientists. Efforts to sustain scholar interest over time and track career trajectories are warranted.

Indexed as

AIDS VaccinesCareer ChoiceCultural DiversityPublic HealthAdultBiomedical ResearchBlack or African AmericanFemaleHispanic or LatinoHumansMaleMentorsUnited StatesAIDS Vaccines

Identifiers

PMID25122028
PMCPMC4358212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.